News

Nightingale Associates appoints
new board director

14 September 2009

Leading science architect, Paul Dempsey, joins Nightingale Associates as the new board-level Science Development Director this month.

Further expanding Nightingale Associates’ science division, Paul Dempsey, has been appointed as Science Development Director. Specialising in the pharmaceutical and science sector, Paul previously worked for CBRE, Pfizer and Bovis Lend Lease Pharmaceutical, bringing a wealth of experience and knowledge to the practice when he starts this month.

His addition to Nightingale Associates aims to build upon the practice’s accomplishments within the science sector, helping to promote the company’s knowledge and innovation.

“I am delighted to be joining Nightingale Associates to help further expand the excellent track record it already has in the science sector. My appointment is intended to boost the science capability with our existing clients and to help develop future work in new and exciting industry sectors.”

Paul Dempsey

And Paul is no stranger to innovation; recognised as a pioneer and leader of ‘Lab of the Future’ projects, he was awarded the prestigious William E Upjohn prize for innovation - and was the first non-scientist award winner in Pfizer’s history for his influential role on the Pfizer FlexiLab projects.

As part of his new role, he will help to develop and maintain Nightingale Associates’ leading profile as thought leaders within the science sector. He will also commission research to support the work of the practice and ensure future science projects continue to be leading-edge. The role also includes chairing the ‘Nightingale science knowledge network’, aiming to dissipate knowledge of scientific developments throughout the company.

“Paul’s appointment is a significant step for us in the development of our specialist team of architects and designers working in the field of Science. His knowledge and expertise in the commercial sector is critical in broadening our service to clients.”

Richard Harrington, Executive Chairman, Nightingale Associates

Paul has extensive experience in Architecture and Strategic Real Estate Planning and has recently returned from working overseas in New York, USA and Europe for six years. Previously Paul has worked for CBRE as a Director of Strategic Planning, for Pfizer as the Director of Global Space Planning and for Bovis Lend Lease Pharmaceutical where he led the design of many complex and innovative pharmaceutical and laboratory projects.

Paul starts in mid-September and will be based in Nightingale Associates’ London office.